Portfolio company
Rubedo
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This biopharmaceutical company develops therapeutics targeting senescent cells to treat chronic age-related diseases for patients with skin and pulmonary conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Rubedo.Life
This company develops small-molecule prodrugs that selectively eliminate senescent cells for patients with age-related chronic diseases and skin conditions.
Rubedo Life Sciences
This company develops small-molecule therapeutics and anti-ageing skin care products for patients with age-related diseases and consumers seeking skin rejuvenation.
Neotis
This company develops immunotherapies targeting senescent cells to treat age-related and fibrotic diseases for patients with chronic conditions.
Deciduous Therapeutics
This company develops small-molecule immunotherapies that activate the immune system to remove senescent cells for patients with age-related, metabolic and fibrotic diseases.
Senisca
This company develops oligonucleotide-based therapeutics that reprogramme senescent cells to treat age-related diseases and aesthetic signs of ageing for patients and pharmaceutical partners.
Altos Labs
This biotechnology company develops cellular rejuvenation therapies to restore cell health and reverse diseases for patients with chronic illnesses and age-related disabilities.
Cleara Biotech
The company develops peptide-based therapies that target and eliminate senescent cells to treat patients with late-stage cancers and age-related chronic diseases.
Centenara Labs
This company develops and invests in therapeutics targeting age-related diseases for patients needing extended healthspan and improved lifespan.
